Dana-Farber experts present innovative cancer studies at the 2025 AACR Annual Meeting

Dana-Farber experts present innovative cancer studies at the 2025 AACR Annual Meeting

Numerous studies conducted by researchers at Dana-Farber Cancer Institute report progress for cancers including head and neck cancer, metastatic breast cancer and lung cancer.

Plenary program to conclude Wednesday with predictive oncology, AACR Annual Meeting takeaways - AACR Annual Meeting News

The final day of the AACR Annual Meeting 2025 will feature two Plenary Sessions, including the morning Plenary Session on Opportunities in Predictive Oncology and a closing Plenary Session to showcase the meeting’s key highlights across the continuum of cancer research. Learn more about Wednesday’s Plenary Sessions below, and refer to the Annual Meeting App and Online Itinerary Planner for the most up-to-date details. Opportunities in Predictive…

Head and Neck, Breast, Lung and Survivorship Studies Headline Dana-Farber Research at AACR Annual Meeting 2025

Dana-Farber Cancer Institute highlights research being presented at the 2025 AACR Annual Meeting.

Dana-Farber Research Highlights Head and Neck, Breast, Lung, and

Researchers at Dana-Farber Cancer Institute are once again at the forefront of oncology innovation, revealing groundbreaking studies set to be unveiled at the forthcoming American Association for Cancer Research (AACR) Annual Meeting, scheduled for April 25-30, 2025, in Chicago. This pivotal gathering will showcase Dana-Farber’s latest advancements in head and neck cancer, metastatic breast cancer, lung cancer, and other malignancies, exemplifyi…

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

Numerous studies conducted by researchers at Dana-Farber Cancer Institute report progress for cancers including head and neck cancer, metastatic breast cancer and lung cancer.